Case Study: Santa Ana Biosciences accelerates R&D and decision making with LatchBio

Santa Ana Biosciences accelerated computational biology decision making 2x

Santa Ana Biosciences, a precision immunology drug development company, sought to accelerate its R&D by overcoming significant data organization, computational scalability, and inefficiency challenges with its existing infrastructure on AWS. Their computational biologists were losing a substantial amount of time to managing data ops and waiting for slow or crashing instances, which hindered their ability to answer critical research questions quickly. This led them to seek a solution from LatchBio.

By implementing LatchBio's platform, specifically its containerized Latch Pods, the team transitioned to a unified, scalable system. This solution provided flexible, on-demand access to computational resources, replacing their expensive and inflexible AWS setup. The results were substantial: decision-making accelerated by 2x, the team saved over $100,000 on software and cloud costs, and each computational biologist reclaimed an estimated 36 days per year. This efficiency gain directly supported the scaling of their T-cell Atlas and contributed to successful FDA IND filings.

Santa Ana Biosciences

Danny Wells

Founder and CTO